Blood Podcast

American Society of Hematology

Acute Myeloid Leukemia

Multiple Myeloma

Sickle Cell Disease

Diffuse Large B-Cell Lymphoma

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Venetoclax

Clinical Trials

Transfusion Medicine

Mantle Cell Lymphoma

Follicular Lymphoma

Graft-Versus-Host Disease

CAR T-Cell Therapy

Acute Lymphoblastic Leukemia

Myelodysplastic Syndromes

Tyrosine Kinase Inhibitors

Hematology

Venous Thromboembolism

Thrombosis

Minimal Residual Disease

The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.

115 ratings

Publishes	Weekly	Episodes	376	Founded	6 years ago
Number of Listeners		Categories	ScienceMedicineHealth & Fitness

Listen to this Podcast

Guests Hosts Reviews Charts Talking Points

Latest Episodes

Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Shengwen Calvin Li and Hrishi Krishna Srinagesh on their latest articles published in Blood. Dr. Li discusses "Single-cell profiling of ANKRD26 thrombocytopenia reveals progenitor e... more

23 Apr 2026 • 19 min

Real-world availability of CAR T-cell therapies

In this week's episode, Blood podcast editor Laurie Sehn interviews Drs. Edward Cliff on his latest research published in volume 147 issue 14 of Blood. Dr. Cliff discusses "Global access to commercial CAR T-cell therapies: a cross-sectional study of ... more

16 Apr 2026 • 9 min

Consequences of p53 loss and Gastrin for aGVHD of the Stomach

In this week's episode, Blood podcast editor Dr. James Griffin interviews authors Drs. Steffen Boettcher and Robert Zeiser on their recent publications in Blood. Dr. Boettcher discusses "Bone marrow failure, somatic rescue by p53 inactivation, and en... more

9 Apr 2026 • 20 min

Review Series on Myeloproliferative Neoplasms

In this episode, Blood Associate Editor Dr. Jason Gotlib discusses the Review Series "The New Wave of Targeted Therapeutics for MPN’s", with authors Drs. Stefan Constantinescu, Ann Mullally, and Marina Kremyanskaya. This Review Series covers 3 areas ... more

2 Apr 2026 • 26 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The HematologistThe Hematologist

Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

HemeTalks: Conversations in Hematology EducationAmerican Society of Hematology

Two Onc DocsSam and Karine

Hematologic Oncology UpdateDr. Neil Love

Recent Guests

Robert Zeiser

Presented the Gastrin paper; Department of Internal Medicine, University of Freiburg, Germany

University of Freiburg

Episode: Consequences of p53 loss and Gastrin for aGVHD of the Stomach

Steffen Boettcher

Presented the ERCC6L2 bone marrow failure paper; Department of Medical Oncology and Hematology, University of Zurich, Switzerland

University of Zurich

Episode: Consequences of p53 loss and Gastrin for aGVHD of the Stomach

Ann Mullally

Co-author of a review on Novel Strategies Targeting CALR in Essential Thrombocythemia and Myelofibrosis

Stanford University School of Medicine; Stanford Cancer Institute

Episode: Review Series on Myeloproliferative Neoplasms

Marina Kremyanskaya

Co-author of a review on Modulators of the Hepcidin Pathway and PV and other MPNs

ICON School of Medicine at Mount Sinai

Episode: Review Series on Myeloproliferative Neoplasms

Stefan Constantinescu

Co-author of a review on Next-generation JAK inhibitors and Kalor-directed therapies

Université Catholique de Louvain; Ludwig Institute for Cancer Research; Oxford

Episode: Review Series on Myeloproliferative Neoplasms

Dr. Jorge Cortes

Cancer Center Director, Medical College of Georgia

Medical College of Georgia

Episode: CH in children with SCD and Asciminib for CML in the ASC4FIRST trial

Dr. Alexander Bick

Associate Professor of Medicine, Vanderbilt University Medical School; Director of the Division of Genetic Medicine

Vanderbilt University Medical School

Episode: CH in children with SCD and Asciminib for CML in the ASC4FIRST trial

Christian Gorzelanny

Researcher; Department of Dermatology, University Medical Center Hamburg-Eppendorf

University Medical Center Hamburg-Eppendorf

Episode: Emerging Mechanisms: Neutrophils and Immune thrombocytopenia from ICI

Rebecca Kaup-Leaf

Clinician-scientist; Division of Hematology-Oncology

Mass General Hospital

Episode: Emerging Mechanisms: Neutrophils and Immune thrombocytopenia from ICI

Hosts

Dr. Laurie Sehn

Podcast Editor at Blood, with expertise in hematology and clinical practice.

James Griffin

Host of the Blood Podcast and associate editor, focusing on hematology advancements.

Reviews

4.2 out of 5 stars from 115 ratings

Zzzz
Listened to a 17-minute episode on Mantle Cell Lymphoma. The first 3 minutes were spent ego-stroking. The podcast content was relevant (though very surface level), but the presentation was so sleepy and boring.
Apple Podcasts
3
Pectown
United States25 days ago
Needs more conversations with better sounding audio
Either sounds like AI summaries or conversations with terrible audio. All the guests are great. Hosts are terrible sounding.
Apple Podcasts
2
adammgaines
United States6 months ago
Needs more conversations with better sounding audio
Either sounds like AI summaries or conversations with terrible audio
Apple Podcasts
1
adammgaines
United Statesa year ago
That’s not how you do a podcast.
Have to agree with other reviewers. The computer generated reader is ghastly.
Apple Podcasts
1
Detritus2099
Australia2 years ago
Great job !!!
It’s so great to know people are working hard for transfusion medicine. It is some of the most neglected aspects in medicine and your podcasts help a lot. Thank you again . I would love to contact you . It has ignited my desire to achieve more
Apple Podcasts
5
all the names are taken taken
India4 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the depth of information shared and the expertise of guests featured, noting it as valuable for staying current in the field.

The podcast is recognized for shedding light on under-discussed issues in transfusion medicine and hematology, which resonates positively with professionals in these areas.

Many comments express concern about the audio quality and delivery style, suggesting that a more conversational approach would enhance their experience.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#228	Italy/Science
Apple Podcasts	#54	Norway/Science
Apple Podcasts	#80	Poland/Science
Apple Podcasts	#85	Japan/Science
Apple Podcasts	#101	Belgium/Science
Apple Podcasts	#162	Indonesia/Science

Talking Points

Recent interactions between the hosts and their guests.

Review Series on Myeloproliferative Neoplasms

Q: What results have been seen with hepcidin pathway modulators in PV, and how might these agents fit into PV management?

Hepcidin agonists like resveratide have shown hematocrit control and reduced need for phlebotomies, with patient-reported symptom improvements; antagonists remain explored to address anemia in myelofibrosis, potentially enabling combination strategies and reducing reliance on phlebotomies or cytoreductive therapy.

Review Series on Myeloproliferative Neoplasms

Q: What is the rationale for targeting CALR and how might CALR-directed therapies achieve clonal eradication?

CALR mutations generate a shared novel C-terminal peptide exposed on the cell surface, enabling highly selective targeting; approaches include monoclonal antibodies to block MPL signaling, bi-specific T cell engagers to recruit T cells to CALR-mutant cells, and vaccines to stimulate endogenous T cell responses, with the goal of eliminating the CALR-mutant clone and achieving disease modification.

Review Series on Myeloproliferative Neoplasms

Q: Could you summarize the major takeaways about the mechanism of action of the currently approved JAK inhibitors and how that informs next-generation design?

The existing JAK inhibitors are Type I, targeting the kinase domain in JAK2 (mutant and wild type) with limited selectivity for the mutant clone; next-generation inhibitors include Type II inhibitors and allosteric inhibitors that aim for greater selectivity, lower collateral hematopoietic toxicity, and potentially deeper allele burden reductions, moving toward clonal selectivity and disease modification.

Consequences of p53 loss and Gastrin for aGVHD of the Stomach

Q: Are there ways to predict which patients might develop stomach GVHD after a transplant?

Serum gastrin levels correlate with risk; lower gastrin is associated with higher non-relapse mortality and worse outcomes, indicating gastrin could serve as a biomarker for risk stratification.

Consequences of p53 loss and Gastrin for aGVHD of the Stomach

Q: Does panogastrin have any effect on the immune response, particularly on T cell activity or T cell mobility?

There are no gastrin receptors on immune cells, but indirect effects may exist; in two leukemia models, the anti-leukemic immune response was preserved despite gastrin treatment, suggesting indirect pathways rather than direct receptor-mediated changes.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Blood Podcast

What is Blood Podcast about and what kind of topics does it cover?

The episodes feature in-depth discussions on the latest advancements and research in hematology, showcasing a range of topics from pediatric venous thromboembolism to the nuances of acute myeloid leukemia treatment. Notable themes include the impact of genetic factors in disease outcomes, innovative immunotherapies, personalized treatment strategies, and emerging research on hematological conditions. Each episode often involves expert guests who share insights from their clinical and research work, enriching the conversation and providing valuable perspectives on significant developments in the field.

Where can I find podcast stats for Blood Podcast?

Rephonic provides a wide range of podcast stats for Blood Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Blood Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Blood Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Blood Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Blood Podcast?

Rephonic provides comprehensive predictive audience data for Blood Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Blood Podcast have?

To see how many followers or subscribers Blood Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Blood Podcast?

These podcasts share a similar audience with Blood Podcast:

1. The Hematologist
2. Blood Cancer Talks
3. HemeTalks: Conversations in Hematology Education
4. Two Onc Docs
5. Hematologic Oncology Update

How many episodes of Blood Podcast are there?

Blood Podcast launched 6 years ago and published 376 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Blood Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Blood Podcast?

Rephonic pulls ratings and reviews for Blood Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Blood Podcast?

Rephonic provides full transcripts for episodes of Blood Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Blood Podcast?

Recent guests on Blood Podcast include:

1. Robert Zeiser
2. Steffen Boettcher
3. Ann Mullally
4. Marina Kremyanskaya
5. Stefan Constantinescu
6. Dr. Jorge Cortes
7. Dr. Alexander Bick
8. Christian Gorzelanny

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days